Cargando…

Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study

BACKGROUND: To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. METHODS: A prospective observational study was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaoxiao, Zhang, He, Shi, Yuanyuan, Yu, Zanzhe, Yan, Hao, Ni, Zhaohui, Qian, Jiaqi, Fang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240212/
https://www.ncbi.nlm.nih.gov/pubmed/30445969
http://dx.doi.org/10.1186/s12967-018-1687-0
_version_ 1783371596851838976
author Yang, Xiaoxiao
Zhang, He
Shi, Yuanyuan
Yu, Zanzhe
Yan, Hao
Ni, Zhaohui
Qian, Jiaqi
Fang, Wei
author_facet Yang, Xiaoxiao
Zhang, He
Shi, Yuanyuan
Yu, Zanzhe
Yan, Hao
Ni, Zhaohui
Qian, Jiaqi
Fang, Wei
author_sort Yang, Xiaoxiao
collection PubMed
description BACKGROUND: To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. METHODS: A prospective observational study was conducted in 324 chronic PD patients. Biochemical analysis was performed at baseline for serum angiopoietins, albumin and high sensitive C-reactive protein (hs-CRP) and echocardiography was done to detect cardiac valvular calcification. Primary study end points were fatal or nonfatal cardiovascular events and mortality. RESULTS: The median of serum Angpt-2 levels was 5.44 ng/mL (interquartile range, 3.41–7.85). Across the three tertiles of serum Angpt-2, a significant trend effect was observed for body mass index, normalized protein catabolic rate, calcium × phosphorus product, hs-CRP, brain natriuretic peptide, lower-density lipoprotein cholesterol, left ventricular ejection fraction, total weekly urea clearance and residual renal function (all p < 0.05). Serum Angpt-2 showed a significant increase across the four groups of patients with increasing components of MIAC syndrome (p < 0.001). There were 77 deaths and 57 cardiovascular events. High serum Angpt-2 was an independent predictor of fatal and nonfatal cardiovascular events in PD patients (p = 0.02), however serum Angpt-2 was not an independent predictor of all-cause mortality (p = 0.3). CONCLUSIONS: Serum Angpt-2 showed close association with valvular calcification, atherosclerosis, inflammation and malnutrition, having significant independent prognostic value and is useful for cardiovascular event stratification in chronic PD patients. Angpt-2 might be a potential mediator of increased cardiovascular risk in patients undergoing PD treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1687-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6240212
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62402122018-11-26 Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study Yang, Xiaoxiao Zhang, He Shi, Yuanyuan Yu, Zanzhe Yan, Hao Ni, Zhaohui Qian, Jiaqi Fang, Wei J Transl Med Research BACKGROUND: To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. METHODS: A prospective observational study was conducted in 324 chronic PD patients. Biochemical analysis was performed at baseline for serum angiopoietins, albumin and high sensitive C-reactive protein (hs-CRP) and echocardiography was done to detect cardiac valvular calcification. Primary study end points were fatal or nonfatal cardiovascular events and mortality. RESULTS: The median of serum Angpt-2 levels was 5.44 ng/mL (interquartile range, 3.41–7.85). Across the three tertiles of serum Angpt-2, a significant trend effect was observed for body mass index, normalized protein catabolic rate, calcium × phosphorus product, hs-CRP, brain natriuretic peptide, lower-density lipoprotein cholesterol, left ventricular ejection fraction, total weekly urea clearance and residual renal function (all p < 0.05). Serum Angpt-2 showed a significant increase across the four groups of patients with increasing components of MIAC syndrome (p < 0.001). There were 77 deaths and 57 cardiovascular events. High serum Angpt-2 was an independent predictor of fatal and nonfatal cardiovascular events in PD patients (p = 0.02), however serum Angpt-2 was not an independent predictor of all-cause mortality (p = 0.3). CONCLUSIONS: Serum Angpt-2 showed close association with valvular calcification, atherosclerosis, inflammation and malnutrition, having significant independent prognostic value and is useful for cardiovascular event stratification in chronic PD patients. Angpt-2 might be a potential mediator of increased cardiovascular risk in patients undergoing PD treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1687-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-16 /pmc/articles/PMC6240212/ /pubmed/30445969 http://dx.doi.org/10.1186/s12967-018-1687-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yang, Xiaoxiao
Zhang, He
Shi, Yuanyuan
Yu, Zanzhe
Yan, Hao
Ni, Zhaohui
Qian, Jiaqi
Fang, Wei
Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_full Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_fullStr Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_full_unstemmed Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_short Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_sort association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240212/
https://www.ncbi.nlm.nih.gov/pubmed/30445969
http://dx.doi.org/10.1186/s12967-018-1687-0
work_keys_str_mv AT yangxiaoxiao associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT zhanghe associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT shiyuanyuan associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT yuzanzhe associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT yanhao associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT nizhaohui associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT qianjiaqi associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT fangwei associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy